Sartorius Concludes Agreement to Acquire the Liquid Handling Business of the Laboratory Supplier Biohit
Sales and purchase agreement signed for 68 million euros
Sartorius signed an agreement to acquire the liquid handling business of the Finnish laboratory supplierBiohit Oyj. With its liquid handling segment, Biohit is one of the global market leaders for mechanical and electronic pipettes, as well as for the associated consumables. The segment, which employs some 400 people, generated net sales of approximately 38 million euros and an EBITDA margin of approx. 13% in fiscal 2010. Its major customers are research, quality assurance and academic laboratories as well as hospitals. This deal will enable Sartorius to expand its product portfolio with an important component in the area of laboratory instruments, which currently includes lab balances, lab water purification systems, moisture analyzers and sample preparation consumables.
Sartorius further extends its lab business
Sartorius
“Pipettes are the ideal addition to our laboratory product offering,” commented Dr. Joachim Kreuzburg, CEO and Executive Board Chairman of Sartorius AG. “Just like our balances, they are among the most frequently used lab instruments with especially high customer requirements regarding their precision, reliability, safety and service support. Biohit is one of the leading suppliers in this field, known worldwide for innovative solutions and high quality. With this acquisition, we will substantially strengthen our strategic positioning with our customers and move significantly toward our goal of serving as a broad-based supplier of high-quality laboratory instruments and consumables supported by excellent service."
Subject to the acquisition are all assets of the liquid handling segment of Biohit Oyj, including its production facilities in Finland and China , as well as its sales subsidiaries in eight countries. The acquisition, which will be carried out through the Sartorius Lab Holding GmbH, will be financed from an existing credit facility, and is projected to be accretive to relevant net profit* for the Sartorius Group already in 2012. This deal, which is subject to customary closing conditions and the approval of the General Meeting of Biohit, is expected to close in December 2011.
Most read news
Topics
Organizations
Other news from the department business & finance
These products might interest you
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Pipetting
Pipetting is one of the most basic yet critical techniques in the laboratory. It enables the precise and controlled transfer of liquids, which is essential for accurate measurements and reliable results. Whether in DNA analysis, cell culture or biochemical assays, correct pipetting significantly influences the quality of the results.
Topic world Pipetting
Pipetting is one of the most basic yet critical techniques in the laboratory. It enables the precise and controlled transfer of liquids, which is essential for accurate measurements and reliable results. Whether in DNA analysis, cell culture or biochemical assays, correct pipetting significantly influences the quality of the results.
Last viewed contents
Differentiating amino acids: Foundation for direct sequencing of individual proteins developed
Research under high pressure - Why 3,000 bars are needed to take a comprehensive look at a protein
Oxford Gene Technology and Abcodia form Partnership - Companies Combine Expertise to Advance Biomarkers for the Early Diagnosis of Pancreatic Cancer
Targeting a large family of parasites - Potential drug target is identified
Sigma-Aldrich strengthens position in RNAi and cell-based assays
Watching the production of new proteins in live cells
Focus Diagnostics - First U.S. Laboratory to License Newly Discovered Coronavirus CoV-NL63 From Primagen
Scientists X-ray chocolate
AI-based analysis system for the diagnosis of breast cancer - For the first time, morphological, molecular and histological data are integrated in a single analysis
New organ-on-chip pilot seeks to reduce animal testing in consumer health industry - Cooperation between Bayer, the start-ups esqLABS and Dynamic42, and Placenta Lab of Jena University Hospital
A vast viral world in wastewater - How metagenomic sequencing helps to understand the spread of viruses